Cellwise(SH:688325)2026-02-27 09:00Financial Performance - The company achieved total operating revenue of RMB 488.66 million, an increase of 24.34% compared to the previous year[3] - Operating profit reached RMB 103.79 million, reflecting a growth of 30.49% year-over-year[3] - The total profit amounted to RMB 99.99 million, up by 29.04% from the previous year[3] - Net profit attributable to shareholders of the parent company was RMB 96.35 million, representing a 22.20% increase year-over-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 86.91 million, an increase of 15.72% compared to the previous year[3] - Basic earnings per share increased to RMB 1.1544, up by 19.84% from the previous year[3] Assets and Equity - Total assets at the end of the reporting period were RMB 1,950.84 million, a growth of 9.43% from the beginning of the period[8] - Shareholders' equity attributable to the parent company was RMB 1,758.21 million, an increase of 2.70% from the beginning of the period[8] - The company’s share capital increased by 1.40% to RMB 86.14 million, primarily due to the exercise of stock options[8] Return on Equity - The company's weighted average return on equity increased by 0.90 percentage points to 5.59%[3]